Fuso Pharmaceutical Industries,Ltd. Financial Overview
Fuso Pharmaceutical Industries,Ltd.'s market cap is currently ¥19.72B. The company's EPS TTM is ¥43.26; its P/E ratio is -4.87; and it has a dividend yield of 3.87%. Fuso Pharmaceutical Industries,Ltd. is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
